{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:31:02Z","timestamp":1790202662148,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Government of the Russian Federation for the state support of scientific research","award":["14.W03.31.0009"],"award-info":[{"award-number":["14.W03.31.0009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11033-021-06565-w","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T17:02:36Z","timestamp":1626973356000},"page":"5745-5758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Pathogenesis of the inflammatory bowel disease in context of SARS-COV-2 infection"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-9824","authenticated-orcid":false,"given":"K. A.","family":"Dvornikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Yu.","family":"Bystrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. P.","family":"Churilov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"issue":"10114","key":"6565_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng SC, Shi HY, Hamidi N, Underwood FE et al (2018) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 390(10114):2769\u20132778. https:\/\/doi.org\/10.1016\/S0140-6736(17)32448-0","journal-title":"Lancet"},{"issue":"3","key":"6565_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/apt.14173","volume":"46","author":"SP Costello","year":"2017","unstructured":"Costello SP, Soo W, Bryant RV et al (2017) Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther 46(3):213\u2013224. https:\/\/doi.org\/10.1111\/apt.14173","journal-title":"Aliment Pharmacol Ther"},{"issue":"22","key":"6565_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG et al (2020) Crohn\u2019s disease. Nat Rev Dis Primers 6(22):1\u201319. https:\/\/doi.org\/10.1038\/s41572-020-0156-2","journal-title":"Nat Rev Dis Primers"},{"key":"6565_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1146\/annurev-immunol-042617-053055","volume":"36","author":"HH Uhlig","year":"2018","unstructured":"Uhlig HH, Powrie F (2018) Translating immunology into therapeutic concepts for inflammatory bowel disease. Annu Rev Immunol 36:755\u2013781. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053055","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"6565_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4103\/sjmms.sjmms_81_18","volume":"7","author":"VA Annese","year":"2019","unstructured":"Annese VA (2019) Review of extraintestinal manifestations and complications of inflammatory bowel disease. Saudi J Med Med Sci 7(2):66\u201373. https:\/\/doi.org\/10.4103\/sjmms.sjmms_81_18","journal-title":"Saudi J Med Med Sci"},{"issue":"3","key":"6565_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2015","unstructured":"Harbord M, Annese V, Vavricka SR, Allez M et al (2015) The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis 10(3):239\u2013254. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv213","journal-title":"J Crohns Colitis"},{"issue":"1","key":"6565_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrgastro.2017.136","volume":"15","author":"AN Ananthakrishnan","year":"2018","unstructured":"Ananthakrishnan AN, Bernstein CN, Iliopoulos D et al (2018) Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol 15(1):39\u201349. https:\/\/doi.org\/10.1038\/nrgastro.2017.136","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6565_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756284819856865","volume":"12","author":"E Klenske","year":"2019","unstructured":"Klenske E, Bojarski C, Waldner M, Rath T et al (2019) Targeting mucosal healing in Crohn\u2019s disease: what the clinician needs to know. Ther Adv Gastroenterol 12:1\u201311. https:\/\/doi.org\/10.1177\/1756284819856865","journal-title":"Ther Adv Gastroenterol"},{"issue":"20","key":"6565_CR9","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","volume":"375","author":"BG Feagan","year":"2016","unstructured":"Feagan BG, Sandborn WJ, Gasink C et al (2016) Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med 375(20):1946\u20131960. https:\/\/doi.org\/10.1056\/NEJMoa1602773","journal-title":"N Engl J Med"},{"key":"6565_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","volume":"14","author":"MA Odenwald","year":"2017","unstructured":"Odenwald MA, Turner JR (2017) The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol 14:9\u201321. https:\/\/doi.org\/10.1038\/nrgastro.2016.169","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"6565_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fmicb.2016.00084","volume":"7","author":"A Lerner","year":"2016","unstructured":"Lerner A, Aminov R, Matthias T (2016) Dysbiosis may trigger autoimmune diseases via inappropriate posttranslational modification of host proteins. Front Microbiol 7:84. https:\/\/doi.org\/10.3389\/fmicb.2016.00084","journal-title":"Front Microbiol"},{"key":"6565_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.intimp.2018.03.002","volume":"59","author":"K Vijay","year":"2018","unstructured":"Vijay K (2018) Toll-like receptors in immunity and inflammatory diseases: past, present, and future. Int Immunopharmacol 59:391\u2013412. https:\/\/doi.org\/10.1016\/j.intimp.2018.03.002","journal-title":"Int Immunopharmacol"},{"issue":"72","key":"6565_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00072","volume":"9","author":"Y Lu","year":"2018","unstructured":"Lu Y, Li X, Liu S et al (2018) Toll-like receptors and inflammatory bowel disease. Front Immunol 9(72):1\u20139. https:\/\/doi.org\/10.3389\/fimmu.2018.00072","journal-title":"Front Immunol"},{"key":"6565_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HSP de Souza","year":"2016","unstructured":"de Souza HSP, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13\u201327. https:\/\/doi.org\/10.1038\/nrgastro.2015.186","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7351","key":"6565_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature10209","volume":"474","author":"B Khor","year":"2011","unstructured":"Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474(7351):307\u2013317. https:\/\/doi.org\/10.1038\/nature10209","journal-title":"Nature"},{"issue":"9","key":"6565_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"JZ Liu","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H et al (2015) Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47(9):979\u2013986. https:\/\/doi.org\/10.1038\/ng.3359","journal-title":"Nat Genet"},{"issue":"3","key":"6565_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","volume":"157","author":"D Piovani","year":"2019","unstructured":"Piovani D, Danese S, Peyrin-Biroulet L et al (2019) Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology 157(3):647-659.e4. https:\/\/doi.org\/10.1053\/j.gastro.2019.04.016","journal-title":"Gastroenterology"},{"key":"6565_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","volume":"152","author":"RB Sartor","year":"2017","unstructured":"Sartor RB, Wu GD (2017) Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology 152:327-339.e4. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.012","journal-title":"Gastroenterology"},{"key":"6565_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12691\/ijcd-8-2-7","volume":"8","author":"A Lerner","year":"2020","unstructured":"Lerner A (2020) Covid-19 and the human gut: a new runner on the tract. Int J Celiac Dis 8:64\u201367. https:\/\/doi.org\/10.12691\/ijcd-8-2-7","journal-title":"Int J Celiac Dis"},{"issue":"6","key":"6565_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ibd\/izaa085","volume":"26","author":"JF Burgueco","year":"2020","unstructured":"Burgueco JF, Reich A, Hazime H et al (2020) Expression of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBD. Inflamm Bowel Dis 26(6):797\u2013808. https:\/\/doi.org\/10.1093\/ibd\/izaa085","journal-title":"Inflamm Bowel Dis"},{"key":"6565_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2018","unstructured":"Cui J, Li F, Shi ZL (2018) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181\u2013192. https:\/\/doi.org\/10.1038\/s41579-018-0118-9","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"6565_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P et al (2020) Coronavirus infections and immune responses. J Med Virol 92(4):424\u2013432. https:\/\/doi.org\/10.1002\/jmv.25685","journal-title":"J Med Virol"},{"issue":"2","key":"6565_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/path.4454","volume":"235","author":"LE Gralinski","year":"2015","unstructured":"Gralinski LE, Baric RS (2015) Molecular pathology of emerging coronavirus infections. J Pathol 235(2):185\u2013195. https:\/\/doi.org\/10.1002\/path.4454","journal-title":"J Pathol"},{"key":"6565_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.14.988345","author":"K Wang","year":"2020","unstructured":"Wang K, Chen W, Zhou YS, Lian JQ et al (2020) SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. https:\/\/doi.org\/10.1101\/2020.03.14.988345","journal-title":"bioRxiv"},{"issue":"3","key":"6565_CR25","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/jcp.27155","volume":"234","author":"S Shokri","year":"2019","unstructured":"Shokri S, Mahmoudvand S, Taherkhani R, Farshadpour F (2019) Modulation of the immune response by middle east respiratory syndrome coronavirus. J Cell Physiol 234(3):2143\u20132151. https:\/\/doi.org\/10.1002\/jcp.27155","journal-title":"J Cell Physiol"},{"issue":"6","key":"6565_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","volume":"26","author":"N Petrosillo","year":"2020","unstructured":"Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E (2020) COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect 26(6):729\u2013734. https:\/\/doi.org\/10.1016\/j.cmi.2020.03.026","journal-title":"Clin Microbiol Infect"},{"issue":"10224","key":"6565_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565\u2013574. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"issue":"7798","key":"6565_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"6565_CR29","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3389\/fmicb.2020.01576","volume":"11","author":"J Wu","year":"2020","unstructured":"Wu J, Yuan X, Wang B, Gu R, Li W, Xiang X, Tang L, Sun H (2020) Severe acute respiratory syndrome coronavirus 2: from gene structure to pathogenic mechanisms and potential therapy. Front Microbiol 11:1576. https:\/\/doi.org\/10.3389\/fmicb.2020.01576","journal-title":"Front Microbiol"},{"issue":"6","key":"6565_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jmv.25754","volume":"92","author":"M Kandeel","year":"2020","unstructured":"Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M (2020) From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol 92(6):660\u2013666. https:\/\/doi.org\/10.1002\/jmv.25754","journal-title":"J Med Virol"},{"issue":"1","key":"6565_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JFW Chan","year":"2020","unstructured":"Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, Yuen KY (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221\u2013236. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","journal-title":"Emerg Microbes Infect"},{"key":"6565_CR32","doi-asserted-by":"publisher","first-page":"100682","DOI":"10.1016\/j.genrep.2020.100682","volume":"19","author":"RA Khailany","year":"2020","unstructured":"Khailany RA, Safdar M, Ozaslan M (2020) Genomic characterization of a novel SARS-CoV-2. Gene Rep 19:100682. https:\/\/doi.org\/10.1016\/j.genrep.2020.100682","journal-title":"Gene Rep"},{"issue":"8","key":"6565_CR33","doi-asserted-by":"publisher","first-page":"102597","DOI":"10.1016\/j.autrev.2020.102597","volume":"19","author":"M Ehrenfeld","year":"2020","unstructured":"Ehrenfeld M, Tincani A, Andreoli L, Cattalini M, Greenbaum A, Kanduc D et al (2020) Covid-19 and autoimmunity. Autoimmun Rev 19(8):102597. https:\/\/doi.org\/10.1016\/j.autrev.2020.102597","journal-title":"Autoimmun Rev"},{"issue":"2","key":"6565_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.22625\/2072-6732-2020-12-2-5-11","volume":"12","author":"VA Zinserling","year":"2020","unstructured":"Zinserling VA, Vashukova MA, Vasilyeva MV, Isakov AN et al (2020) Issues of pathology of a new coronavirus infection COVID-19. Jurnal infectologii 12(2):5\u201311. https:\/\/doi.org\/10.22625\/2072-6732-2020-12-2-5-11","journal-title":"Jurnal infectologii"},{"issue":"2","key":"6565_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q (2021) COVID-19 and autoimmune diseases. Curr Opin Rheumatol 33(2):155\u2013162. https:\/\/doi.org\/10.1097\/BOR.0000000000000776","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"6565_CR36","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/antib9030033","volume":"9","author":"D Kanduc","year":"2020","unstructured":"Kanduc D (2020) From anti-SARS-CoV-2 immune responses to COVID-19 via molecular mimicry. Antibodies 9(3):33. https:\/\/doi.org\/10.3390\/antib9030033","journal-title":"Antibodies"},{"key":"6565_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s12192-020-01148-3","volume":"25","author":"A Marino Gammazza","year":"2020","unstructured":"Marino Gammazza A, L\u00e9gar\u00e9 S, Lo Bosco G et al (2020) Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19. Cell Stress Chaperones 25:737\u2013741. https:\/\/doi.org\/10.1007\/s12192-020-01148-3","journal-title":"Cell Stress Chaperones"},{"issue":"5","key":"6565_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s12192-020-01145-6","volume":"25","author":"G Lucchese","year":"2020","unstructured":"Lucchese G, Fl\u00f6el A (2020) SARS-CoV-2 and Guillain-Barr\u00e9 syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones 25(5):731\u2013735. https:\/\/doi.org\/10.1007\/s12192-020-01145-6","journal-title":"Cell Stress Chaperones"},{"key":"6565_CR39","doi-asserted-by":"publisher","first-page":"e58603","DOI":"10.7554\/eLife.58603","volume":"9","author":"P Anand","year":"2020","unstructured":"Anand P, Puranik A, Aravamudan M, Venkatakrishnan AJ, Soundararajan V (2020) SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. Elife 9:e58603. https:\/\/doi.org\/10.7554\/eLife.58603","journal-title":"Elife"},{"issue":"12","key":"6565_CR40","doi-asserted-by":"publisher","first-page":"102695","DOI":"10.1016\/j.autrev.2020.102695","volume":"19","author":"G Halpert","year":"2020","unstructured":"Halpert G, Shoenfeld Y (2020) SARS-CoV-2, the autoimmune virus. Autoimmun Rev 19(12):102695. https:\/\/doi.org\/10.1016\/j.autrev.2020.102695","journal-title":"Autoimmun Rev"},{"issue":"1","key":"6565_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s12026-016-8817-7","volume":"65","author":"MT Arango","year":"2016","unstructured":"Arango MT, Perricone C, Kivity S et al (2016) HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol Res 65(1):82\u201398. https:\/\/doi.org\/10.1007\/s12026-016-8817-7","journal-title":"Immunol Res"},{"issue":"2","key":"6565_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.medin.2020.08.004","volume":"45","author":"L Lorente","year":"2021","unstructured":"Lorente L, Mart\u00edn MM, Franco A et al (2021) HLA genetic polymorphisms and prognosis of patients with COVID-19. Polimorfismos gen\u00e9ticos de los HLA y pron\u00f3stico de pacientes con COVID-19. Med Intensiva 45(2):96\u2013103. https:\/\/doi.org\/10.1016\/j.medin.2020.08.004","journal-title":"Med Intensiva"},{"issue":"4","key":"6565_CR43","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/iid3.358","volume":"8","author":"Y Tomita","year":"2020","unstructured":"Tomita Y, Ikeda T, Sato R, Sakagami T (2020) Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis. Immun Inflamm Dis 8(4):684\u2013694. https:\/\/doi.org\/10.1002\/iid3.358","journal-title":"Immun Inflamm Dis"},{"key":"6565_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0014-5793(02)03640-2","volume":"532","author":"D Harmer","year":"2002","unstructured":"Harmer D, Gilbert M, Borman R, Clark KL (2002) Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett 532:107\u2013110. https:\/\/doi.org\/10.1016\/s0014-5793(02)03640-2","journal-title":"FEBS Lett"},{"issue":"6","key":"6565_CR45","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","volume":"158","author":"F Xiao","year":"2020","unstructured":"Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H (2020) Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158(6):1831-1833.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.055","journal-title":"Gastroenterology"},{"issue":"6","key":"6565_CR46","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/jmv.25742","volume":"92","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wang S, Xue Y (2020) Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol 92(6):680\u2013682. https:\/\/doi.org\/10.1002\/jmv.25742","journal-title":"J Med Virol"},{"issue":"5","key":"6565_CR47","doi-asserted-by":"publisher","first-page":"790","DOI":"10.14309\/ajg.0000000000000610","volume":"115","author":"L Chen","year":"2020","unstructured":"Chen L, Lou J, Bai Y, Wang M (2020) COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests. Am J Gastroenterol 115(5):790. https:\/\/doi.org\/10.14309\/ajg.0000000000000610","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"6565_CR48","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.14309\/ajg.0000000000000691","volume":"115","author":"C Ma","year":"2020","unstructured":"Ma C, Cong Y, Zhang H (2020) COVID-19 and the digestive system. Am J Gastroenterol 115(7):1003\u20131006. https:\/\/doi.org\/10.14309\/ajg.0000000000000691","journal-title":"Am J Gastroenterol"},{"key":"6565_CR49","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.30.927806","author":"H Zhang","year":"2020","unstructured":"Zhang H, Kang Z, Gong H et al (2020) The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes. bioRxiv. https:\/\/doi.org\/10.1101\/2020.01.30.927806","journal-title":"bioRxiv"},{"issue":"1","key":"6565_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.12116\/j.issn.1004-5619.2020.01.005","volume":"36","author":"Q Liu","year":"2020","unstructured":"Liu Q, Wang RS, Qu GQ et al (2020) Gross observation report on autopsy of dead corpse system of covid-19. J Forensic Med 36(1):21\u201323. https:\/\/doi.org\/10.12116\/j.issn.1004-5619.2020.01.005","journal-title":"J Forensic Med"},{"issue":"6","key":"6565_CR51","doi-asserted-by":"publisher","first-page":"942","DOI":"10.14309\/ajg.0000000000000667","volume":"115","author":"A Carvalho","year":"2020","unstructured":"Carvalho A, Alqusairi R, Adams A, Paul M, Kothari N, Peters S, DeBenedet AT (2020) SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: implications for detection and transmission of COVID-19 disease. Am J Gastroenterol 115(6):942\u2013946. https:\/\/doi.org\/10.14309\/ajg.0000000000000667","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"6565_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jceh.2020.03.001","volume":"10","author":"A Agarwal","year":"2020","unstructured":"Agarwal A, Chen A, Ravindran N, To C, Thuluvath PJ (2020) Gastrointestinal and liver manifestations of COVID-19. J Clin Exp Hepatol 10(3):263\u2013265. https:\/\/doi.org\/10.1016\/j.jceh.2020.03.001","journal-title":"J Clin Exp Hepatol"},{"issue":"5","key":"6565_CR53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS (2020) Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 5(5):428\u2013430. https:\/\/doi.org\/10.1016\/S2468-1253(20)30057-1","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7408","key":"6565_CR54","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Perlot T, Rehman A et al (2012) ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487(7408):477\u2013481. https:\/\/doi.org\/10.1038\/nature11228","journal-title":"Nature"},{"issue":"1","key":"6565_CR55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3785\/j.issn.1008-9292.2020.02.02","volume":"49","author":"K Xu","year":"2020","unstructured":"Xu K, Cai H, Shen Y et al (2020) Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban 49(1):147\u2013157. https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2020.02.02","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"6565_CR56","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9(1):727\u2013732. https:\/\/doi.org\/10.1080\/22221751.2020.1746199","journal-title":"Emerg Microbes Infect"},{"key":"6565_CR57","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1136\/gutjnl-2019-318427","volume":"68","author":"M Camilleri","year":"2019","unstructured":"Camilleri M (2019) Leaky gut: mechanisms, measurement and clinical implications in humans. Gut 68:1516\u20131526. https:\/\/doi.org\/10.1136\/gutjnl-2019-318427","journal-title":"Gut"},{"key":"6565_CR58","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1053\/j.gastro.2012.01.031","volume":"142","author":"E Thachil","year":"2012","unstructured":"Thachil E, Hugot JP, Arbeille B et al (2012) Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn\u2019s disease. Gastroenterology 142:1097\u20131099. https:\/\/doi.org\/10.1053\/j.gastro.2012.01.031","journal-title":"Gastroenterology"},{"issue":"4","key":"6565_CR59","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","volume":"44","author":"JY Yang","year":"2016","unstructured":"Yang JY, Kim MS, Kim E et al (2016) Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-\u03b2 production. Immunity 44(4):889\u2013900. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.009","journal-title":"Immunity"},{"key":"6565_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25987","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Mukherjee S (2020) In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.25987","journal-title":"J Med Virol"},{"issue":"4","key":"6565_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.dsx.2020.04.020","volume":"14","author":"I Astuti","year":"2020","unstructured":"Astuti I (2020) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Diabetes Metab Syndr 14(4):407\u2013412. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.020","journal-title":"Diabetes Metab Syndr"},{"issue":"12","key":"6565_CR62","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1136\/gutjnl-2013-305870","volume":"63","author":"A Deiteren","year":"2014","unstructured":"Deiteren A, De Man JG, Ruyssers NE, Moreels TG, Pelckmans PA, De Winter BY (2014) Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity. Gut 63(12):1873\u20131882. https:\/\/doi.org\/10.1136\/gutjnl-2013-305870","journal-title":"Gut"},{"key":"6565_CR63","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","volume":"11","author":"DF Van den Berg","year":"2020","unstructured":"Van den Berg DF, te Velde AA (2020) Severe COVID-19: NLRP3 inflammasome dysregulated. Front Immunol 11:1580. https:\/\/doi.org\/10.3389\/fimmu.2020.01580","journal-title":"Front Immunol"},{"key":"6565_CR64","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fimmu.2020.00211","volume":"11","author":"C Zhao","year":"2020","unstructured":"Zhao C, Zhao W (2020) NLRP3 inflammasome\u2014a key player in antiviral responses. Front Immunol 11:211. https:\/\/doi.org\/10.3389\/fimmu.2020.00211","journal-title":"Front Immunol"},{"issue":"4","key":"6565_CR65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/gut.2009.192567","volume":"59","author":"N Cenac","year":"2010","unstructured":"Cenac N, Altier C, Motta JP, d\u2019Aldebert E, Galeano S, Zamponi GW, Vergnolle N (2010) Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity. Gut 59(4):481\u2013488. https:\/\/doi.org\/10.1136\/gut.2009.192567","journal-title":"Gut"},{"key":"6565_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","volume":"10","author":"IY Chen","year":"2019","unstructured":"Chen IY, Moriyama M, Chang MF, Ichinohe T (2019) Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol 10:50. https:\/\/doi.org\/10.3389\/fmicb.2019.00050","journal-title":"Front Microbiol"},{"key":"6565_CR67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","volume":"10","author":"Y Zhen","year":"2019","unstructured":"Zhen Y, Zhang H (2019) NLRP3 inflammasome and inflammatory bowel disease. Front Immunol 10:276. https:\/\/doi.org\/10.3389\/fimmu.2019.00276","journal-title":"Front Immunol"},{"issue":"2","key":"6565_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cytogfr.2011.02.001","volume":"22","author":"M Yu","year":"2011","unstructured":"Yu M, Levine SJ (2011) Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev 22(2):63\u201372. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.02.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"6565_CR69","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130(5):2620\u20132629. https:\/\/doi.org\/10.1172\/JCI137244","journal-title":"J Clin Invest"},{"key":"6565_CR70","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/imr.12726","volume":"287","author":"J Pazmandi","year":"2019","unstructured":"Pazmandi J, Kalinichenko A, Ardy RC, Boztug K (2019) Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms. Immunology 287:162\u2013185. https:\/\/doi.org\/10.1111\/imr.12726","journal-title":"Immunology"},{"issue":"7","key":"6565_CR71","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","volume":"69","author":"MF Neurath","year":"2020","unstructured":"Neurath MF (2020) Covid-19 and immunomodulation in IBD. Gut 69(7):1335\u20131342. https:\/\/doi.org\/10.1136\/gutjnl-2020-321269","journal-title":"Gut"},{"issue":"2","key":"6565_CR72","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14740\/gr740w","volume":"10","author":"L Zhu","year":"2017","unstructured":"Zhu L, Shi T, Zhong C, Wang Y, Chang M, Liu X et al (2017) IL-10 and IL-10 receptor mutations in very early onset inflammatory bowel disease. Gastroenterol Res 10(2):65\u201369. https:\/\/doi.org\/10.14740\/gr740w","journal-title":"Gastroenterol Res"},{"issue":"11","key":"6565_CR73","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3748\/wjg.v27.i11.1022","volume":"27","author":"JMF Chebli","year":"2021","unstructured":"Chebli JMF, Queiroz NSF, Dami\u00e3o AOMC et al (2021) How to manage inflammatory bowel disease during the COVID-19 pandemic: a guide for the practicing clinician. World J Gastroenterol 27(11):1022\u20131042. https:\/\/doi.org\/10.3748\/wjg.v27.i11.1022","journal-title":"World J Gastroenterol"},{"issue":"10","key":"6565_CR74","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/ibd\/izaa170","volume":"26","author":"M Aziz","year":"2020","unstructured":"Aziz M, Fatima R, Haghbin H, Lee-Smith W, Nawras A (2020) The incidence and outcomes of COVID-19 in IBD patients: a rapid review and meta-analysis. Inflamm Bowel Dis 26(10):e132\u2013e133. https:\/\/doi.org\/10.1093\/ibd\/izaa170","journal-title":"Inflamm Bowel Dis"},{"issue":"10","key":"6565_CR75","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/bjs.11670","volume":"107","author":"K S\u00f8reide","year":"2020","unstructured":"S\u00f8reide K, Hallet J, Matthews JB et al (2020) Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg 107(10):1250\u20131261. https:\/\/doi.org\/10.1002\/bjs.11670","journal-title":"Br J Surg"},{"key":"6565_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13193-020-01254-9","volume":"18","author":"SP Somashekhar","year":"2020","unstructured":"Somashekhar SP, Acharya R, Saklani A et al (2020) Adaptations and safety modifications to perform safe Minimal Access Surgery (MIS: Laparoscopy and Robotic) during the COVID-19 pandemic: practice modifications expert panel consensus guidelines from Academia of Minimal Access Surgical Oncology (AMASO). Indian J Surg Oncol 18:1\u201311. https:\/\/doi.org\/10.1007\/s13193-020-01254-9","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"6565_CR77","doi-asserted-by":"publisher","first-page":"e18928","DOI":"10.2196\/18928","volume":"6","author":"RA de Leeuw","year":"2020","unstructured":"de Leeuw RA, Burger NB, Ceccaroni M et al (2020) COVID-19 and laparoscopic surgery: scoping review of current literature and local expertise. JMIR Public Health Surveill 6(2):e18928. https:\/\/doi.org\/10.2196\/18928","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"6565_CR78","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1053\/j.gastro.2020.04.002","volume":"159","author":"DT Rubin","year":"2020","unstructured":"Rubin DT, Abreu MT, Rai V, Siegel CA (2020) International Organization for the study of inflammatory bowel disease: management of patients with Crohn\u2019s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an International Meeting. Gastroenterology 159(1):6\u201313. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.002","journal-title":"Gastroenterology"},{"issue":"2","key":"6565_CR79","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","volume":"159","author":"EJ Brenner","year":"2020","unstructured":"Brenner EJ, Ungaro RC, Gearry RB et al (2020) Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry. Gastroenterology 159(2):481-491.e3. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.032","journal-title":"Gastroenterology"},{"issue":"11","key":"6565_CR80","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/ecco-jcc\/jjaa120","volume":"14","author":"S Sebastian","year":"2020","unstructured":"Sebastian S, Gonzalez HA, Peyrin-Biroulet L (2020) Safety of drugs during previous and current coronavirus pandemics: lessons for inflammatory bowel disease. J Crohns Colitis 14(11):1632\u20131643. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa120","journal-title":"J Crohns Colitis"},{"key":"6565_CR81","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395:473\u2013475. https:\/\/doi.org\/10.1016\/S0140-6736(20)30317-2","journal-title":"Lancet"},{"issue":"4","key":"6565_CR82","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/gutjnl-2020-322539","volume":"70","author":"RC Ungaro","year":"2021","unstructured":"Ungaro RC, Brenner EJ, Gearry RB et al (2021) Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut 70(4):725\u2013732. https:\/\/doi.org\/10.1136\/gutjnl-2020-322539","journal-title":"Gut"},{"issue":"1","key":"6565_CR83","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.gastro.2020.04.012","volume":"159","author":"DT Rubin","year":"2020","unstructured":"Rubin DT, Feuerstein JD, Wang AY, Cohen RD (2020) AGA clinical practice update on management of inflammatory bowel disease during the COVID-19 pandemic: expert commentary. Gastroenterology 159(1):350\u2013357. https:\/\/doi.org\/10.1053\/j.gastro.2020.04.012","journal-title":"Gastroenterology"},{"issue":"11","key":"6565_CR84","doi-asserted-by":"publisher","first-page":"102390","DOI":"10.1016\/j.autrev.2019.102390","volume":"18","author":"Y Jamilloux","year":"2019","unstructured":"Jamilloux Y, El Jammal T, Vuitton L et al (2019) JAK inhibitors for the treatment of autoimmune and inflammatory diseases. Autoimmun Rev 18(11):102390. https:\/\/doi.org\/10.1016\/j.autrev.2019.102390","journal-title":"Autoimmun Rev"},{"issue":"10241","key":"6565_CR85","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C et al (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395(10241):e30\u2013e31. https:\/\/doi.org\/10.1016\/S0140-6736(20)30304-4","journal-title":"Lancet"},{"issue":"11","key":"6565_CR86","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/ibd\/izy153","volume":"24","author":"SC Ng","year":"2018","unstructured":"Ng SC, Hilmi IN, Blake A et al (2018) Low frequency of opportunistic infections in patients receiving vedolizumab in clinical trials and post-marketing setting. Inflamm Bowel Dis 24(11):2431\u20132441. https:\/\/doi.org\/10.1093\/ibd\/izy153","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"6565_CR87","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40264-019-00797-3","volume":"42","author":"S Ghosh","year":"2019","unstructured":"Ghosh S, Gensler LS, Yang Z et al (2019) Ustekinumab safety in psoriasis, psoriatic arthritis, and Crohn\u2019s disease: an integrated analysis of phase II\/III clinical development programs. Drug Saf 42(6):751\u2013768. https:\/\/doi.org\/10.1007\/s40264-019-00797-3","journal-title":"Drug Saf"},{"issue":"10","key":"6565_CR88","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.14309\/ajg.0000000000000817","volume":"115","author":"GR Lichtenstein","year":"2020","unstructured":"Lichtenstein GR, Rubin DT (2020) Coronavirus and patients with inflammatory bowel disease: management strategies for the practicing clinician. Am J Gastroenterol 115(10):1566\u20131569. https:\/\/doi.org\/10.14309\/ajg.0000000000000817","journal-title":"Am J Gastroenterol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06565-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06565-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T19:09:21Z","timestamp":1628104161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06565-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6565"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06565-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"17 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflict of interests for all the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}